National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 274314

History of Changes from the VAERS Wayback Machine

First Appeared on 12/31/2007

VAERS ID: 274314
Age:
Gender:Female
Location:Florida
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2007-03-14
Entered:2007-03-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 - / IM

Administered by: Other      Purchased by: Unknown
Symptoms: Dizziness, Nausea

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type':

Write-up:Information has been received from a female consumer (age unknown) who, on an unspecified date, was vaccinated intramuscularly with a second dose of Gardasil. Subsequently, on an unknown date, the patient experienced nausea and dizziness after receiving t"he second dose of vaccine which was administered with a regular needle. Symptoms subsided after 15-20 minutes. The reporting physician stated that the patient was not affected by the first dose of vaccine which was administered with a safety syringe. The


Changed on 12/8/2009

VAERS ID: 274314 Before After
Age:
Gender:Female
Location:Florida
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2007-03-14
Entered:2007-03-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 - / IM

Administered by: Other      Purchased by: Unknown Other
Symptoms: Dizziness, Nausea

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type': (blank) WAES0702USA03704

Write-up:Information has been received from a female consumer (age unknown) who, on an unspecified date, was vaccinated intramuscularly with a second dose of Gardasil. Subsequently, on an unknown date, the patient experienced nausea and dizziness after receiving t"he the second dose of vaccine which was administered with a regular needle. Symptoms subsided after 15-20 minutes. The reporting physician stated that the patient was not affected by the first dose of vaccine which was administered with a safety syringe. The patient sought unspecified medical attention. Subsequently, the patient recovered from nausea and dizziness. No product quality complaint was involved. Additional information has been requested.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=274314&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166